Oxotremorine sesquifumarate |
| カタログ番号GC16156 |
オキソトレモリン セスキフマレートは、主に M2 受容体を活性化する mAChR アゴニストです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 17360-35-9
Sample solution is provided at 25 µL, 10mM.
評判の良い論文で引用されたGlpBio製品
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 17360-35-9 | SDF | |
| Chemical Name | 1-(4-(pyrrolidin-1-yl)but-2-yn-1-yl)pyrrolidin-2-one sesquifumarate | ||
| Canonical SMILES | O=C1CCCN1CC#CCN2CCCC2.O=C3CCCN3CC#CCN4CCCC4.O=C(O)/C([H])=C([H])/C(O)=O.O=C(O)/C([H])=C([H])/C(O)=O.O=C(O)/C([H])=C([H])/C(O)=O | ||
| Formula | C12H18N2O.1.5C4H4O4 | M.Wt | 380.4 |
| 溶解度 | <38.04mg/ml in DMSO; <9.51mg/ml in Water | Storage | Store at RT |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6288 mL | 13.1441 mL | 26.2881 mL |
| 5 mM | 0.5258 mL | 2.6288 mL | 5.2576 mL |
| 10 mM | 0.2629 mL | 1.3144 mL | 2.6288 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC33546 Tos-Gly-Pro-Arg-ANBA-IPA acetate (tos-GPR-ANBA-IPA acetate)
- GC12841 CEP 1347
- GC14258 SR 27897
- GC36095 G-5555 hydrochloride
- GC12512 Losartan Carboxylic Acid
- GC15257 Perhexiline (maleate)
- GC33432 TBHBA (2,4,6-Tribromo-3-hydroxybenzoic acid)
- GC39378 Emedastine
- GC11178 A-7 hydrochloride
- GC19297 Mitapivat
- GC11602 Piribedil dihydrochloride
- GC43898 Imipenem (hydrate)
- GC19761 6-Acetonyldihydrosanguinarine
- GC42584 6-O-desmethyl Donepezil
- GC41864 10,13-epoxy-10,12-Octadecadienoic Acid
- GC18041 NESS 0327
- GC60074 BI-2545
レビュー
Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *